|Articles|November 19, 2015

Michael J. Mauro Discusses the Diagnosis of CML

Michael J. Mauro, leader, Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses the diagnosis of chronic myeloid leukemia (CML).

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!

Related Content

For Silvia Davis, a breast cancer diagnosis at the age of 36 led to a fertility preservation journey that resulted in her son, John.

Fertility Preservation During Breast Cancer: ‘I Would Do It All Again’

BySilvia Davis

November 1st 2025

What Are My Options for Liver Cancer Treatment?

ByDr. Anjana Pillai

October 31st 2025

New Directions in Treatment for Patients With GIST

ByDr. Vinayak Venkataraman

October 30th 2025

Experts Break Down Key Insights During Breast Cancer Awareness Month

ByDr. Komal Jhaveri,Dr. Sheldon Marc Feldman,Dr. Evan Garfein

October 30th 2025

Keeping Her Hair Helped Her Feel Normal During Breast Cancer Treatment

ByMaureen Green

October 30th 2025

Michael J. Mauro Discusses the Diagnosis of CML

Newsletter

Related Content

Fertility Preservation During Breast Cancer: ‘I Would Do It All Again’

What Are My Options for Liver Cancer Treatment?

New Directions in Treatment for Patients With GIST

Experts Break Down Key Insights During Breast Cancer Awareness Month

Keeping Her Hair Helped Her Feel Normal During Breast Cancer Treatment

Trending on CURE

Living With Leukemia Chester Freeman Embraces Wabi-Sabi

Fertility Preservation During Breast Cancer: ‘I Would Do It All Again’

Becoming Cancer-Aware: How My Diagnosis Changed the Way My Family Sees Everyday Products

What Are My Options for Liver Cancer Treatment?

Understanding Clinical Trial Site Supply and Access